Evaluation of a Prototype for an Innovative Room for the Elderly
Condition(s) studied
Investigational drug(s) / intervention(s)
Hospi'Senior: The Hospi'Senior room is equipped with conventional furnishings (same bed and same armchair as a conventional room) to which have been added technological innovations and innovations in furnishings. Innovative technologies cover bed equipment, patient mobility (autonomous and assisted), lighting, communication and social space.
Conventional room: The conventional room is a classic hospital room not equipped with the innovative technologies found in the Hospi'Senior room. The room is equipped with a bed, bedside table, adjustable bed table with castors and an armchair.
Study summary
The Groupement de Coopération Sanitaire des Hôpitaux Universitaires du Grand Ouest (GCS HUGO) (health cooperation group for university hospitals in the west of France), is proposing to improve the quality of geriatric care by modernizing hospital rooms. The GCS HUGO has embarked on a project to co-design a hospital room adapted for the elderly, called "Hospi'Senior", with the help of the "Dépendance et Grand âge" (Dependency and Old Age) steering committee, made up of experts from HUGO's establishments and experts from several companies.
Eligibility
Primary outcome measure(s)
- Length of stay in the short-stay geriatric unit — This outcome is assessed at the end of the geriatric unit stay (up to 2 months)
The length of stay is measured in days
Trial sites (5)
| Facility | City | Region | Status |
|---|---|---|---|
| Angers University Hospital | Angers | France | Recruiting |
| Brest University Hospital | Brest | France | Recruiting |
| Nantes University Hospital | Nantes | France | Recruiting |
| Rennes University Hospital | Rennes | France | Recruiting |
| Tours University Hospital | Tours | France | Recruiting |
More University Hospital, Angers trials in France
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06098534 on ClinicalTrials.gov ↗ ← All trials in France